Search - tctmd.com

Displaying 841 - 860 of 1832

Sort: Relevancy | Date

News Daily News

Women Underrepresented in Pivotal Studies Leading to FDA Drug Approval

Michael O'Riordan

May 01, 2018

News Conference News SCAI 2018

Largest CTO PCI Registry to Date Confirms Feasibility, in Expert Hands

Yael L. Maxwell

April 26, 2018

Presentation ECHO 2018

When Contrast Saves the Day and other Diagnostic Conundrums

Presenter: Leo Marcoff

April 19, 2018

Presentation ECHO 2018

Echo Contrast Cases - EtOHSeptal Ablation

Presenter: Omar Khalique

April 19, 2018

News Daily News

Value of Ambulatory BP Monitoring Bolstered by Large Study

Todd Neale

April 18, 2018

News Daily News

Silent MI Often Precedes Acute MI, Portends Worse Patient Outcomes

Shelley Wood

April 18, 2018

Presentation ECHO 2018

Clinical Applications of Contrast (Ultrasound Enhancing Agents) 2018

Presenter: Linda D. Gillam

April 18, 2018

News Industry News

Boston Scientific Announces Acquisition of Securus Medical Group, Inc.

April 10, 2018

News Daily News

Pills or Even Tea More Palatable Than Exercise for the Treatment of Hypertension, US Adults Say

Michael O'Riordan

April 09, 2018

News Daily News

Real-World Study Raises Concerns About Initiating Carotid Stenting in Acute Phase

L.A. McKeown

April 03, 2018

News Daily News

Time for Guidelines to Recommend ARBs Over ACE Inhibitors?

Shelley Wood

March 29, 2018

News Daily News

Videos Boost Oral and Written Explanations to Help Patients Understand PCI

L.A. McKeown

March 29, 2018

News Daily News

No Link Between Operator Volume and Post-PCI Mortality in the UK

Todd Neale

March 27, 2018

News Daily News

Quicker Diuretics Not Associated With Better Outcomes in Acute Heart Failure

Todd Neale

March 25, 2018

News Conference News ACC 2018

Urgent/Emergent TAVR: Risky but Rewarding, TVT Registry Data Hint

Caitlin E. Cox

March 19, 2018

News Conference News ACC 2018

Salt in the Wound: Experts Clash Over Ideal Sodium Targets in Hypertension

Michael O'Riordan

March 15, 2018

News Conference News ACC 2018

PFO Closure Guided by High-Risk Features on Echo Shows Benefit in DEFENSE-PFO

Shelley Wood

March 15, 2018

News Conference News ACC 2018

Precision Medicine Gamble Fails for CETP Inhibitors in ACCELERATE Analysis

Michael O'Riordan

March 14, 2018

ACC 2018, Day Three: Gout, Hypertension, and Diabetes Dominate Opening Late Breaker

News Conference News ACC 2018

ACC 2018, Day Three: Gout, Hypertension, Diabetes, PFO Closure, DAPT, NOAC Reversal, and More

Shelley Wood

March 12, 2018

News Conference News ACC 2018

Genetic Testing Influences Post-PCI Antiplatelet Prescriptions, but Other Factors Also Play a Role

Yael L. Maxwell

March 11, 2018

Advertisement

Women Underrepresented in Pivotal Studies Leading to FDA Drug Approval

Largest CTO PCI Registry to Date Confirms Feasibility, in Expert Hands

When Contrast Saves the Day and other Diagnostic Conundrums

Echo Contrast Cases - EtOHSeptal Ablation

Value of Ambulatory BP Monitoring Bolstered by Large Study

Silent MI Often Precedes Acute MI, Portends Worse Patient Outcomes

Clinical Applications of Contrast (Ultrasound Enhancing Agents) 2018

Boston Scientific Announces Acquisition of Securus Medical Group, Inc.

Pills or Even Tea More Palatable Than Exercise for the Treatment of Hypertension, US Adults Say

Real-World Study Raises Concerns About Initiating Carotid Stenting in Acute Phase

Time for Guidelines to Recommend ARBs Over ACE Inhibitors?

Videos Boost Oral and Written Explanations to Help Patients Understand PCI

No Link Between Operator Volume and Post-PCI Mortality in the UK

Quicker Diuretics Not Associated With Better Outcomes in Acute Heart Failure

Urgent/Emergent TAVR: Risky but Rewarding, TVT Registry Data Hint

Salt in the Wound: Experts Clash Over Ideal Sodium Targets in Hypertension

PFO Closure Guided by High-Risk Features on Echo Shows Benefit in DEFENSE-PFO

Precision Medicine Gamble Fails for CETP Inhibitors in ACCELERATE Analysis

ACC 2018, Day Three: Gout, Hypertension, Diabetes, PFO Closure, DAPT, NOAC Reversal, and More

Genetic Testing Influences Post-PCI Antiplatelet Prescriptions, but Other Factors Also Play a Role

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content